|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,125,160 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,064,010 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 24 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-01-02 |
4 |
AS |
$68.90 |
$344,483 |
I/I |
(5,000) |
50,740 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-09-28 |
4 |
A |
$69.08 |
$14,438 |
D/D |
209 |
5,668 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
AS |
$69.11 |
$552,896 |
I/I |
(8,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-10-25 |
4 |
AS |
$69.55 |
$347,750 |
D/D |
(5,000) |
327,520 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-12-05 |
4 |
AS |
$69.70 |
$348,485 |
I/I |
(5,000) |
50,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-01-10 |
4 |
AS |
$70.00 |
$350,000 |
I/I |
(5,000) |
50,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-08-20 |
4 |
AS |
$70.00 |
$350,000 |
I/I |
(5,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.17 |
$1,052,492 |
I/I |
(15,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.74 |
$1,773,551 |
I/I |
(25,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-16 |
4 |
OE |
$71.33 |
$356,650 |
D/D |
5,000 |
195,674 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-03-31 |
4 |
A |
$72.47 |
$14,494 |
D/D |
200 |
591 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-03-20 |
4 |
D |
$73.05 |
$959,000 |
D/D |
(13,128) |
297,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-09-16 |
4 |
AS |
$73.08 |
$146,163 |
I/I |
(2,000) |
48,740 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-03-31 |
4 |
A |
$73.23 |
$17,282 |
D/D |
236 |
7,700 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$630,850 |
D/D |
(8,525) |
1,200 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$88,800 |
D/D |
(1,200) |
0 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-09-30 |
4 |
A |
$74.23 |
$16,256 |
D/D |
219 |
7,274 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-21 |
4 |
AS |
$75.00 |
$150,000 |
I/I |
(2,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-11-11 |
4 |
A |
$75.38 |
$754 |
D/D |
10 |
327,080 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-12 |
4 |
AS |
$77.10 |
$539,700 |
D/D |
(7,000) |
295,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-16 |
4 |
D |
$77.21 |
$429,210 |
D/D |
(5,559) |
308,017 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-05-10 |
4 |
AS |
$77.29 |
$657,970 |
D/D |
(8,513) |
303,839 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-10 |
4 |
AS |
$77.57 |
$1,163,550 |
D/D |
(15,000) |
338,569 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-11-22 |
4 |
AS |
$77.60 |
$776,000 |
D/D |
(10,000) |
327,080 |
0 |
- |
|
850 Records found
|
|
Page 24 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|